コーパス検索結果 (left1)
通し番号をクリックするとPubMedの該当ページを表示します
1 MC3R cell types in DMH are sexually dimorphic.
2 MC3R deletion produced multiple forms of sexually dimorp
3 MC3R neurons in PVT are innervated by hypothalamic AgRP
4 MC3R(hDM/hDM) bone- and adipose tissue-derived mesenchym
5 MC3R(hDM/hDM) impacts nutrient partitioning to generate
6 MC3R(hDM/hDM) mice do not have increased adipose tissue
7 MC3R-deficient (MC3R(-)(/)(-)) mice demonstrate increase
8 MC3R-deficient hepatocytes had blunted autophagosome-lys
9 MC3Rs are expressed in hypothalamic and limbic regions o
12 s, melanocortin-4 (MC4R) and melanocortin-3 (MC3R), are involved in the regulation of satiety and ene
16 and natural [agouti-related protein (AGRP)] MC3R antagonists but not by the MC4R antagonist Ac-Cys-N
22 at the mouse melanocortin receptors MC1R and MC3R-MC5R and human melanocytes known to express the MC1
27 ptomic data showed coexpression of MRAP2 and MC3R in hypothalamic neurons that function in energy hom
32 reopening of the superior mesenteric artery, MC3R-null mice displayed a higher degree of plasma extra
34 was used to examine the associations between MC3R polymorphisms and the measures of energy balance.
35 nce of a tonic inhibitory signal provided by MC3R in the mesenteric microcirculation of the mouse, ac
40 ons of Cre-recombinase to selectively delete MC3R from the medial hypothalamus (MH) in adult mice.
42 useful for in vivo studies to differentiate MC3R vs MC4R physiological roles in animal models, such
47 Herein, 46 tetrapeptides were chosen for MC3R agonist screening selectivity profiles, synthesized
52 42 (Ac-Val-Gln-(pI)DPhe-DTic-NH(2)), a full MC3R agonist that is 100-fold selective for the MC3R ove
53 rphisms in the melanocortin-3 receptor gene (MC3R) coding sequence, C17A and G241A, has been reported
54 le-mutant (C17A+G241A) human (MC3R(hDM/hDM)) MC3R, that MC3R(hDM/hDM) have greater weight and fat mas
55 In vitro and in vivo activation of hepatic MC3R upregulates autophagy through LC3II activation, TFE
56 the intracellular cAMP accumulation in human MC3R, MC4R, and MC5R revealed that the native peptide sh
60 /hWT)) and double-mutant (C17A+G241A) human (MC3R(hDM/hDM)) MC3R, that MC3R(hDM/hDM) have greater wei
61 we replace murine Mc3r with wild-type human (MC3R(hWT/hWT)) and double-mutant (C17A+G241A) human (MC3
64 ted LoF NSVs may suggest that dysfunction in MC3R is associated with decreased body height, obesity a
65 addition, the alpha-MSH-induced increase in MC3R neuron activity was independent of fast synaptic tr
67 0), but not Arg(7), result in an increase in MC3R selectivity over the MC4R and MC5R and only agonist
69 ng Fos IHC following low-dose liraglutide in MC3R-KO mice (Mc3r-/-), supporting the hypothesis that t
70 mans who carry loss-of-function mutations in MC3R, including a rare homozygote individual, have a lat
72 ssing enhanced yellow fluorescent protein in MC3R neurons to test how alpha-MSH affects the activity
73 arcuate nucleus exerts an important role in MC3R-mediated effects on energy homeostasis, viral delet
74 mentary chemogenetic approaches were used in MC3R-Cre mice to localize and characterize the specific
75 -MSH led to accumulation of cAMP, indicating MC3R receptor functionality: this effect was blocked by
85 h human melanocortin receptor subtypes MC1R, MC3R, MC4R, or MC5R, were then obtained and characterize
86 n 2 (FABP2), melanocortin 2 receptor (MC2R), MC3R, PPARG coactivator 1 alpha (PPARGC1A), and tumor ne
92 rmine whether MRAP2 affected the activity of MC3R, which is structurally similar to MC4R and which re
94 late, results primarily in the antagonism of MC3R and MC4R then allowed us to search the published li
95 dy is to determine the structural aspects of MC3R responsible for ligand binding and receptor signali
96 ever, the specific molecular determinants of MC3R responsible for ligand binding and receptor signali
98 used to map signaling pathways downstream of MC3R and to deduce transcription factors responsible for
99 MRAP2 enhanced cAMP signaling downstream of MC3R, impaired beta-arrestin recruitment to MC3R, and re
103 ion to map changes in the mRNA expression of MC3R, pro-opiomelanocortin and agouti-related peptide fo
107 on energy rheostasis result from the loss of MC3R signalling in medial hypothalamic neurons and sugge
108 3R neurons and pharmacologic manipulation of MC3R each exerted potent bidirectional regulation over f
112 We Sanger sequenced the coding region of MC3R in 185 children or adolescents with short normal st
114 implicate MRAP2 as an important regulator of MC3R function and provide further evidence for the cruci
118 rformed on these animals to test the role of MC3R in MH in the acute response to orexigenic and anore
121 ptide template were selected solely based on MC3R agonist potency from the mixture-based screen.
122 lly, we show that the effect of alpha-MSH on MC3R neuron firing rate is probably activity-dependent.
123 mutations impairing the function of MC4R or MC3R were associated with severe obesity in North Americ
124 ectivity (223- to 467-fold) toward MC4R over MC3R and MC5R receptor subtypes without compromising ago
125 MC4R, was more than 200-fold selective over MC3R, and had a good pharmacokinetic profile in mice, in
128 Consistently, chemogenetic activation of PVT MC3R neurons increases anxiety-related behavior and redu
132 esses downstream of melanocortin 3 receptor (MC3R) activation by endogenous agonists derived from the
133 and antagonists of melanocortin-3 receptor (MC3R) and MC4R point to the importance of the CNS melano
134 ortin (POMC) at the melanocortin 3 receptor (MC3R) and melanocortin 4 receptor (MC4R) and has been pr
139 ogical roles of the melanocortin-3 receptor (MC3R) is lacking because of the limited number of known
140 ed an impact of the melanocortin 3 receptor (MC3R) on the regulation of body weight, linear growth an
143 ')(7)), reported as melanocortin-3 receptor (MC3R) subtype-specific agonists in two separate publicat
145 lated receptor, the Melanocortin-3 receptor (MC3R), could also be a cause of severe human obesity.
148 ive deletion of the melanocortin-3-receptor (MC3R) impairs the behavioural response to both anorexic
150 ous antagonist of the melanocortin receptors MC3R and MC4R found in the hypothalamus and exhibits pot
151 ous antagonist of the melanocortin receptors MC3R and MC4R found in the hypothalamus and exhibits pot
156 melanocortin-3 and melanocortin-4 receptors (MC3R and MC4R, respectively) are established targets to
157 melanocortin-3 and melanocortin-4 receptors (MC3R, MC4R) are involved in the metabolic and food intak
158 melanocortin-3 and melanocortin-4 receptors (MC3R, MC4R) are key regulators of body weight and energy
161 y expressed melanocortin-3 and -4 receptors (MC3R/MC4R) have been studied as possible targets for wei
163 Two of the five melanocortin receptors, MC3R and MC4R are involved in hypothalamic control of en
166 ogical treatment of animals with a selective MC3R agonist ([D-Trp(8)]-gamma-melanocyte-stimulating ho
167 lpha-MSH, melanotan II (MTII), and selective MC3R or MC4R agonists were all inhibitory, reducing the
168 e of the recent description of the selective MC3R agonist [d-Trp(8)]-gamma-melanocyte-stimulating hor
169 ata support the development of the selective MC3R agonist [d-Trp(8)]-gamma-MSH for the treatment of i
173 from identified neurons, we demonstrate that MC3R and MC4R agonists depolarize arcuate POMC neurons a
175 Together, these results demonstrate that MC3R-mediated effects on energy rheostasis result from t
177 C17A+G241A) human (MC3R(hDM/hDM)) MC3R, that MC3R(hDM/hDM) have greater weight and fat mass, increase
179 luorescence photobleaching steps showed that MC3R and MRAP2 readily formed heterodimers, most commonl
181 P1 receptor (GLP1R) analogs, suggesting that MC3R antagonists or MC4R agonists may have value in enha
184 native peptide shows potent activity at the MC3R (EC(50) = 5.9 nM) and is about 50-100-fold selectiv
187 1 order of magnitude (IC(50) = 6 nM) at the MC3R compared with that of the natural molecule and an i
189 10-fold more potent (IC(50) = 8.8 nM) at the MC3R compared with the native peptide but lacks subtype
192 melanocortin neurons selectively express the MC3R, which provides a neuroanatomical basis for a dual-
193 highly selective antagonist analogue for the MC3R (560-fold vs the hMC4R and about 3000-fold vs the h
194 ly, the DTyr(1) peptide is selective for the MC3R (EC(50) = 12 nM) by 40-200-fold compared with the M
195 50) = 11 nM) analogues are selective for the MC3R by 1 and 2 orders of magnitude compared with the MC
196 ecule and an increase in selectivity for the MC3R by 2 orders of magnitude compared with the activity
198 R agonist that is 100-fold selective for the MC3R over the muM MC4R partial agonist pharmacology.
201 ously showed that intra-VTA injection of the MC3R agonist, MTII, decreases home-cage food intake and
202 be for the investigation of the roles of the MC3R and MC4R in diseases of dysregulated energy homeost
204 eletion or pharmacological inhibition of the MC3R, or subthreshold doses of an MC4R agonist, improved
205 Mc3r-/-), supporting the hypothesis that the MC3R is a negative regulator of circuits that control mu
208 gonist ligand for the hMC5R (560-fold vs the MC3R and 1000-fold vs the MC4R); (2) compound 7, Ac-c[Cy
209 ed G protein-coupled receptors, of which the MC3R and MC4R subtypes are implicated in the regulation
210 rent target transcription factors within the MC3R signaling cascade play important roles in immune re
212 tion of calories, whereas signalling through MC3R primarily regulates the disposition of calories int
216 by alanine mutagenesis of five MRAP2 and two MC3R transmembrane residues identified by structural hom
217 viously reported children homozygous for two MC3R sequence variants (C17A+G241A) have greater fat mas
219 he His(6) position can determine MC4R versus MC3R agonist selectivity and that chemically nonreactive
220 tified a new and novel >200-fold MC4R versus MC3R selective peptide Tyr-c[Asp-D-Phe-Arg-Trp-Asn-Ala-P
222 metabolism involves divergent pathways; VMH MC3R signaling improves metabolic homeostasis but does n
225 receptor (Mc3R)-expressing VMH neurons (VMH(MC3R)) sense glucose changes both directly and indirectl
226 synaptic nodes that potentially regulate VMH(MC3R) neuronal activity, including inputs from proopiome
228 Overall, these findings demonstrate that VMH(MC3R) neurons are a glucose-responsive hypothalamic subp
229 ment of 1, a potent, selective (1184-fold vs MC3R, 350-fold vs MC5R), small-molecule agonist of the M
231 ovide a foundation for future studies of VTA MC3R neurons and the circuits containing them in the con
232 both the efferent projection patterns of VTA MC3R neurons and the location of the neurons providing a
233 gnificantly increased the firing rate of VTA MC3R neurons without altering the activity of non-MC3R e
235 te nucleus made few direct synapses onto VTA MC3R neurons or any of the other major neuronal subtypes
236 pitous discovery of nine compounds that were MC3R agonists (EC50 < 1000 nM) and MC4R antagonists (5.7
239 o both anorexic and orexigenic stimuli, with MC3R knockout mice demonstrating increased weight gain f